Fig. 1From: The associations of hepatic steatosis and fibrosis using fatty liver index and BARD score with cardiovascular outcomes and mortality in patients with new-onset type 2 diabetes: a nationwide cohort studySubgroup analysis for mortality in patients with NAFLD (fatty liver index ≥ 60) compared to those without NAFLD (fatty liver index < 30). CI, confidence interval; HR, hazard ratio; NAFLD, non-alcoholic fatty liver diseaseBack to article page